"Go and see your doctor if you've got anything that you're concerned about – that's what a [doctor] is for," Brian Gemmell ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer and neuroendocrine carcinomas. The first patient was dosed in the SKYBRIDGE ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

Today, the American Lung Association’s LUNG FORCE initiative celebrates Lung Cancer Action Week in California, proclaimed the second week of May, uniting America to stand against lung cancer, the ...